Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures

In vivoandin vitrodistribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

(2011) Sophie Escutenaire et al.   ANNALS OF MEDICINE

In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus

(2011) R.E. Adamson et al.   HUMAN GENE THERAPY

A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer

(2011) M.K. Magnusson et al.   HUMAN GENE THERAPY

CD46 processing: A means of expression

(2011) Siobhan Ni Choileain et al.   IMMUNOBIOLOGY

A rapid generation of adenovirus vector with a genetic modification in hexon protein

(2011) Bingyan Di et al.   JOURNAL OF BIOTECHNOLOGY

Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors

(2011) D. Yu et al.   JOURNAL OF VIROLOGY

Ex vivo gene transfer and correction for cell-based therapies

(2011) Luigi Naldini   NATURE REVIEWS GENETICS

Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT Imaging

(2011) J. Michael Mathis et al.   PLoS One

Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation

(2011) W. C. Adams et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

T-cell therapy for cytomegalovirus infection

(2010) Tan S Mui et al.   Current Opinion in Organ Transplantation

Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability

(2010) Justyna Leja et al.   PLoS One

Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens

(2009) Steven M. Pollard et al.   Cell Stem Cell

Human Islet Separation Utilizing a Closed Automated Purification System

(2009) A. S. Friberg et al.   CELL TRANSPLANTATION

Current Advances and Travails in Islet Transplantation

(2009) D. M. Harlan et al.   DIABETES

Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting

(2009) Neus Bayo-Puxan et al.   HUMAN GENE THERAPY

Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function

(2008) Richard J. Stanton et al.   BIOTECHNIQUES

Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells

(2008) Ole Forsberg et al.   BRITISH JOURNAL OF HAEMATOLOGY

Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region

(2008) A Danielsson et al.   CANCER GENE THERAPY

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

(2008) Simon N. Waddington et al.   CELL

Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX

(2008) J de Vrij et al.   GENE THERAPY

Prostate Cancer Stem Cells: A New Target for Therapy

(2008) Norman J. Maitland et al.   JOURNAL OF CLINICAL ONCOLOGY

Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency

(2008) Yasuo Yoshioka et al.   LIFE SCIENCES

Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to Liver

(2008) Frédéric Vigant et al.   MOLECULAR THERAPY

Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo

(2008) O. Kalyuzhniy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA